Abstract:This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder. Summary. Randomized clinical trials are a powerful tool for investigating causal treatment effects, but in human trials there are oftentimes problems of noncompliance which standard analyses, such as the intention-to-treat or as-treated analysis, either ignore or incorporate in such a way that the resulting estimand is no longer a causal effect. One alternative to these analyses is the complier average causal effect (CACE) which estimates the average causal treatment effect among a subpopulation that would comply under any treatment assigned. We focus on the setting of a randomized clinical trial with crossover treatment noncompliance (e.g., control subjects could receive the intervention and intervention subjects could receive the control) and outcome nonresponse. In this article, we develop estimators for the CACE using multiple imputation methods, which have been successfully applied to a wide variety of missing data problems, but have not yet been applied to the potential outcomes setting of causal inference. Using simulated data we investigate the finite sample properties of these estimators as well as of competing procedures in a simple setting. Finally we illustrate our methods using a real randomized encouragement design study on the effectiveness of the influenza vaccine. 1. Introduction The focus of empirical studies in medicine is often to estimate the causal effect of treatments, where randomized clinical trials are considered the most acceptable tool for investigating these causal relationships. But in trials involving human subjects there are oftentimes problems of patient noncompliance, where the patient does not adhere to the treatment assigned. In addition, there is also the problem of nonignorable missing data, where the missing-data mechanism may depend on unobserved data. Standard methods and analyses either ignore these complications, which can lead to biased estimates of causal treatment effect, or account for them in such a way that the resulting estimand can no longer be considered a causal effect of treatment. A statistical framework for causal inference that deals with the issue of noncompliance is based on potential outcomes and was first introduced by Neyman (1923) for randomized studies and later developed by Rubin (1974, 1978) for nonrandomized studies and other forms of inference. Rubin's approach, sometimes referred to as the Ru-bin Causal Model (Holland, 1986), provides a framework for defining the parameters of interest and correctly attributing the …

A novel statistical method for comparing effectiveness of two treatments-simulated randomized controlled trials

Exploring Statistical Methods in Clinical Trials When Some of the Patients are Treated against the Randomization

Comparison of statistical methods for the analysis of patient-reported outcomes in randomised controlled trials: A simulation study

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

Comparison of tests for categorical data from a stratified cluster randomized trial

A Practical Analysis Procedure on Generalizing Comparative Effectiveness in the Randomized Clinical Trial to the Real-world Trialeligible Population

A nonparametric relative treatment effect for direct comparisons of censored paired survival outcomes

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects

A comparison of methods for estimating the average treatment effect on the treated for externally controlled trials

A Novel Statistical Test for Treatment Differences in Clinical Trials using a Response Adaptive Forward Looking Gittins Index Rule

Comparing the Performance of Statistical Adjustment Methods By Recovering the Experimental Benchmark from the REFLUX Trial

Comparative Effectiveness Without Head-to-Head Trials

Intent-to-treat Analysis of Cluster Randomized Trials when Clusters Report Unidentifiable Outcome Proportions.

Series 2-19-2009 Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials

Covariate-adjusted Group Sequential Comparisons of Survival Probabilities

The use of real-world data for clinical investigation of effectiveness in drug development

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

Mathematical programming tools for randomization purposes in small two-arm clinical trials: A case study with real data

Detecting critical treatment effect bias in small subgroups

Design and analysis considerations for comparing dynamic treatment regimens with binary outcomes from sequential multiple assignment randomized trials

Mathematical programming tools for randomization purposes in small two‐arm clinical trials: A case study with real data